Immune Cell Transcriptomic Changes in CSF of Women with Neuropsychiatric Long COVID

Overview

This study identifies distinct gene expression changes in cerebrospinal fluid (CSF) immune cells of women experiencing neuropsychiatric symptoms following COVID-19, highlighting compartment-specific molecular alterations. Differential expression analyses reveal enrichment of oxidative stress and cellular stress pathways in CSF, distinct from peripheral blood mononuclear cells (PBMC), underscoring unique central nervous system immune responses in neuropsychiatric Long COVID.

Background

Long COVID is characterized by persistent symptoms following SARS-CoV-2 infection, with neuropsychiatric manifestations disproportionately affecting women. Symptoms such as cognitive impairment, mood alterations, and fatigue significantly impact quality of life. The underlying molecular mechanisms, particularly within the central nervous system, remain poorly understood. This study investigates gene expression profiles in CSF and PBMC to elucidate CNS-specific changes associated with neuropsychiatric Long COVID in women.

Data Highlights

Twenty-two women with neuropsychiatric Long COVID and 10 women without persistent symptoms were enrolled. RNA sequencing of CSF cells and PBMCs identified differentially expressed genes related to oxidative stress, reactive oxygen species, and P53 response uniquely in CSF. Shared dysregulated pathways in both CSF and PBMC included androgen response, MTORC1 signaling, and lipid metabolism.

Key Findings

• Women with neuropsychiatric Long COVID exhibit unique CSF-specific gene expression changes not observed in peripheral blood.
• CSF cells show enrichment of genes involved in oxidative stress, reactive oxygen species, and P53-mediated cellular stress responses.
• Both CSF and PBMC samples from Long COVID patients demonstrate dysregulation in androgen response, MTORC1 signaling, and lipid metabolism pathways.
• The molecular profiles suggest compartment-specific immune responses within the central nervous system distinct from peripheral immune alterations.
• These findings provide evidence for CNS-specific transcriptional changes underlying neuropsychiatric symptoms post-COVID-19 in women.

Clinical Implications

Understanding CSF-specific molecular alterations in women with neuropsychiatric Long COVID may guide targeted therapeutic strategies addressing central nervous system immune dysregulation. Clinicians should consider the compartmentalized nature of immune responses when evaluating and managing post-COVID neuropsychiatric symptoms. Further research into oxidative stress and cellular stress pathways could inform biomarker development and novel interventions.

Conclusion

This study reveals distinct transcriptional changes in CSF immune cells of women with neuropsychiatric Long COVID, highlighting the importance of CNS-specific molecular investigations. These insights advance understanding of post-viral neurological syndromes and may inform future diagnostic and therapeutic approaches.

References

1. World Health Organization 2021 -- Definition of Long COVID
2. COVID Mind Study, Yale University -- Participant Enrollment and Sample Processing